FTUS
BBP icon

Flow Traders U.S.’s Virtus Biotech ETF BBP Stock Holding History

Flow Traders U.S.’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,613
Closed -$463K – 907
2025
Q3 		$463K Sell
6,613
-790
-11% -$51.7K 0.02% 627
2025
Q2 		$431K Buy
+7,403
New +$418K 0.02% 650

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $309M AUM 22.32% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
CFP
Comprehensive Financial Planning East Petersburg, Pennsylvania $144M AUM 25.61% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Flow Traders U.S.'s BBP Position: Q4 2025 in Review

Flow Traders U.S. sold out of Virtus Biotech ETF (BBP) in Q4 2025, closing a stake of 6,613 shares — an estimated $463K sold.

Flow Traders U.S. first reported a position in BBP in Q2 2025 and held it in 2 quarters. The position peaked at $463K in Q3 2025. 20 funds tracked by Wall St. Rank hold BBP as of Q4 2025.

  • Flow Traders U.S. reported no remaining Virtus Biotech ETF position as of Q4 2025 after selling out during the quarter.
  • Flow Traders U.S. sold 6,613 Virtus Biotech ETF shares in Q4 2025, an estimated $463K.
  • Flow Traders U.S. first reported a position in Virtus Biotech ETF in Q2 2025 and held it in 2 quarters.
  • Flow Traders U.S.'s Virtus Biotech ETF position peaked at $463K in Q3 2025.
  • 20 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q4 2025.

Based on Flow Traders U.S.'s 13F filing for Q4 2025, filed 13 Feb 2026.